nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentamidine—CYP1A1—Progesterone—uterine cancer	0.106	0.168	CbGbCtD
Pentamidine—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.092	0.146	CbGbCtD
Pentamidine—CYP3A5—Progesterone—uterine cancer	0.0634	0.101	CbGbCtD
Pentamidine—CYP2C8—Progesterone—uterine cancer	0.061	0.097	CbGbCtD
Pentamidine—CYP2C19—Progesterone—uterine cancer	0.0511	0.0814	CbGbCtD
Pentamidine—CYP1A2—Progesterone—uterine cancer	0.0472	0.0751	CbGbCtD
Pentamidine—CYP2D6—Progesterone—uterine cancer	0.0389	0.0619	CbGbCtD
Pentamidine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0373	0.0594	CbGbCtD
Pentamidine—CYP3A5—Etoposide—uterine cancer	0.0284	0.0451	CbGbCtD
Pentamidine—CYP2C8—Etoposide—uterine cancer	0.0273	0.0434	CbGbCtD
Pentamidine—CYP3A4—Progesterone—uterine cancer	0.0247	0.0393	CbGbCtD
Pentamidine—CYP1A2—Etoposide—uterine cancer	0.0211	0.0336	CbGbCtD
Pentamidine—CYP2D6—Doxorubicin—uterine cancer	0.0119	0.0189	CbGbCtD
Pentamidine—S100B—artery—uterine cancer	0.0113	0.14	CbGeAlD
Pentamidine—CYP3A4—Etoposide—uterine cancer	0.0111	0.0176	CbGbCtD
Pentamidine—TRDMT1—uterus—uterine cancer	0.00901	0.111	CbGeAlD
Pentamidine—TRDMT1—female reproductive system—uterine cancer	0.0081	0.1	CbGeAlD
Pentamidine—CYP3A4—Doxorubicin—uterine cancer	0.00755	0.012	CbGbCtD
Pentamidine—AOC1—decidua—uterine cancer	0.00464	0.0574	CbGeAlD
Pentamidine—AOC1—renal system—uterine cancer	0.00456	0.0563	CbGeAlD
Pentamidine—AOC1—endometrium—uterine cancer	0.00441	0.0545	CbGeAlD
Pentamidine—AOC1—mammalian vulva—uterine cancer	0.00426	0.0527	CbGeAlD
Pentamidine—CYP4A11—renal system—uterine cancer	0.00378	0.0468	CbGeAlD
Pentamidine—AOC1—female reproductive system—uterine cancer	0.00365	0.0451	CbGeAlD
Pentamidine—Ospemifene—ESR1—uterine cancer	0.00356	1	CrCbGaD
Pentamidine—AOC1—vagina—uterine cancer	0.0033	0.0408	CbGeAlD
Pentamidine—CYP4A11—vagina—uterine cancer	0.00274	0.0339	CbGeAlD
Pentamidine—AOC1—lymph node—uterine cancer	0.00213	0.0264	CbGeAlD
Pentamidine—S100B—lymph node—uterine cancer	0.00186	0.023	CbGeAlD
Pentamidine—CYP2C8—renal system—uterine cancer	0.00093	0.0115	CbGeAlD
Pentamidine—CYP1A1—epithelium—uterine cancer	0.000926	0.0114	CbGeAlD
Pentamidine—CYP1A1—uterine cervix—uterine cancer	0.000918	0.0113	CbGeAlD
Pentamidine—CYP2C8—endometrium—uterine cancer	0.000899	0.0111	CbGeAlD
Pentamidine—CYP3A5—uterine cervix—uterine cancer	0.000897	0.0111	CbGeAlD
Pentamidine—CYP1A2—renal system—uterine cancer	0.00087	0.0108	CbGeAlD
Pentamidine—CYP1A1—renal system—uterine cancer	0.000858	0.0106	CbGeAlD
Pentamidine—CYP3A5—renal system—uterine cancer	0.000839	0.0104	CbGeAlD
Pentamidine—CYP1A1—mammalian vulva—uterine cancer	0.000803	0.00993	CbGeAlD
Pentamidine—CYP2C19—vagina—uterine cancer	0.000772	0.00954	CbGeAlD
Pentamidine—CYP1A1—uterus—uterine cancer	0.000765	0.00945	CbGeAlD
Pentamidine—CYP2C8—female reproductive system—uterine cancer	0.000745	0.00921	CbGeAlD
Pentamidine—CYP1A1—female reproductive system—uterine cancer	0.000688	0.0085	CbGeAlD
Pentamidine—CYP2C8—vagina—uterine cancer	0.000674	0.00833	CbGeAlD
Pentamidine—CYP3A4—renal system—uterine cancer	0.00063	0.00779	CbGeAlD
Pentamidine—CYP1A1—female gonad—uterine cancer	0.000626	0.00773	CbGeAlD
Pentamidine—CYP1A1—vagina—uterine cancer	0.000622	0.00769	CbGeAlD
Pentamidine—CYP2D6—renal system—uterine cancer	0.00062	0.00766	CbGeAlD
Pentamidine—CYP3A5—female gonad—uterine cancer	0.000612	0.00756	CbGeAlD
Pentamidine—CYP3A5—vagina—uterine cancer	0.000608	0.00752	CbGeAlD
Pentamidine—CYP3A4—female reproductive system—uterine cancer	0.000505	0.00624	CbGeAlD
Pentamidine—CYP2D6—female reproductive system—uterine cancer	0.000496	0.00614	CbGeAlD
Pentamidine—CYP2D6—female gonad—uterine cancer	0.000452	0.00558	CbGeAlD
Pentamidine—CYP1A1—lymph node—uterine cancer	0.000402	0.00497	CbGeAlD
Pentamidine—Vomiting—Progesterone—uterine cancer	0.000261	0.00107	CcSEcCtD
Pentamidine—Renal failure acute—Epirubicin—uterine cancer	0.00026	0.00107	CcSEcCtD
Pentamidine—Rash—Progesterone—uterine cancer	0.000259	0.00106	CcSEcCtD
Pentamidine—Dermatitis—Progesterone—uterine cancer	0.000259	0.00106	CcSEcCtD
Pentamidine—Phlebitis—Doxorubicin—uterine cancer	0.000257	0.00106	CcSEcCtD
Pentamidine—Headache—Progesterone—uterine cancer	0.000257	0.00106	CcSEcCtD
Pentamidine—Diabetes mellitus—Doxorubicin—uterine cancer	0.000255	0.00105	CcSEcCtD
Pentamidine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000255	0.00105	CcSEcCtD
Pentamidine—Hepatic function abnormal—Doxorubicin—uterine cancer	0.000254	0.00104	CcSEcCtD
Pentamidine—Decreased appetite—Dactinomycin—uterine cancer	0.000252	0.00104	CcSEcCtD
Pentamidine—Dysgeusia—Etoposide—uterine cancer	0.000252	0.00103	CcSEcCtD
Pentamidine—Renal impairment—Epirubicin—uterine cancer	0.000252	0.00103	CcSEcCtD
Pentamidine—Fatigue—Dactinomycin—uterine cancer	0.00025	0.00103	CcSEcCtD
Pentamidine—Pain—Dactinomycin—uterine cancer	0.000248	0.00102	CcSEcCtD
Pentamidine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000246	0.00101	CcSEcCtD
Pentamidine—Eye pain—Doxorubicin—uterine cancer	0.000246	0.00101	CcSEcCtD
Pentamidine—Hypoglycaemia—Epirubicin—uterine cancer	0.000246	0.00101	CcSEcCtD
Pentamidine—Cerebrovascular accident—Epirubicin—uterine cancer	0.000245	0.001	CcSEcCtD
Pentamidine—Lethargy—Epirubicin—uterine cancer	0.000245	0.001	CcSEcCtD
Pentamidine—Nausea—Progesterone—uterine cancer	0.000244	0.001	CcSEcCtD
Pentamidine—Renal failure acute—Doxorubicin—uterine cancer	0.00024	0.000986	CcSEcCtD
Pentamidine—Feeling abnormal—Dactinomycin—uterine cancer	0.000239	0.000982	CcSEcCtD
Pentamidine—Anaemia—Etoposide—uterine cancer	0.000238	0.000977	CcSEcCtD
Pentamidine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000237	0.000974	CcSEcCtD
Pentamidine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000237	0.000971	CcSEcCtD
Pentamidine—Affect lability—Epirubicin—uterine cancer	0.000236	0.000968	CcSEcCtD
Pentamidine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000235	0.000963	CcSEcCtD
Pentamidine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000234	0.000962	CcSEcCtD
Pentamidine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000233	0.000957	CcSEcCtD
Pentamidine—Renal impairment—Doxorubicin—uterine cancer	0.000233	0.000956	CcSEcCtD
Pentamidine—Face oedema—Epirubicin—uterine cancer	0.000231	0.00095	CcSEcCtD
Pentamidine—Vertigo—Etoposide—uterine cancer	0.000231	0.000949	CcSEcCtD
Pentamidine—Leukopenia—Etoposide—uterine cancer	0.00023	0.000946	CcSEcCtD
Pentamidine—Body temperature increased—Dactinomycin—uterine cancer	0.000229	0.000942	CcSEcCtD
Pentamidine—Abdominal pain—Dactinomycin—uterine cancer	0.000229	0.000942	CcSEcCtD
Pentamidine—Hypoglycaemia—Doxorubicin—uterine cancer	0.000227	0.000932	CcSEcCtD
Pentamidine—Mood swings—Epirubicin—uterine cancer	0.000227	0.000932	CcSEcCtD
Pentamidine—Loss of consciousness—Etoposide—uterine cancer	0.000226	0.000929	CcSEcCtD
Pentamidine—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000226	0.000929	CcSEcCtD
Pentamidine—Lethargy—Doxorubicin—uterine cancer	0.000226	0.000929	CcSEcCtD
Pentamidine—Cough—Etoposide—uterine cancer	0.000225	0.000922	CcSEcCtD
Pentamidine—Blood creatinine increased—Epirubicin—uterine cancer	0.000224	0.000921	CcSEcCtD
Pentamidine—Convulsion—Etoposide—uterine cancer	0.000223	0.000916	CcSEcCtD
Pentamidine—Hypertension—Etoposide—uterine cancer	0.000222	0.000912	CcSEcCtD
Pentamidine—Liver function test abnormal—Epirubicin—uterine cancer	0.000221	0.000908	CcSEcCtD
Pentamidine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000221	0.000907	CcSEcCtD
Pentamidine—Dry skin—Epirubicin—uterine cancer	0.00022	0.000902	CcSEcCtD
Pentamidine—Chest pain—Etoposide—uterine cancer	0.000219	0.0009	CcSEcCtD
Pentamidine—Affect lability—Doxorubicin—uterine cancer	0.000218	0.000896	CcSEcCtD
Pentamidine—Discomfort—Etoposide—uterine cancer	0.000217	0.000889	CcSEcCtD
Pentamidine—Face oedema—Doxorubicin—uterine cancer	0.000214	0.000879	CcSEcCtD
Pentamidine—Hypersensitivity—Dactinomycin—uterine cancer	0.000214	0.000878	CcSEcCtD
Pentamidine—Gastritis—Epirubicin—uterine cancer	0.000212	0.00087	CcSEcCtD
Pentamidine—Confusional state—Etoposide—uterine cancer	0.000212	0.00087	CcSEcCtD
Pentamidine—Anaphylactic shock—Etoposide—uterine cancer	0.00021	0.000862	CcSEcCtD
Pentamidine—Mood swings—Doxorubicin—uterine cancer	0.00021	0.000862	CcSEcCtD
Pentamidine—Infection—Etoposide—uterine cancer	0.000209	0.000857	CcSEcCtD
Pentamidine—Asthenia—Dactinomycin—uterine cancer	0.000208	0.000855	CcSEcCtD
Pentamidine—Blood creatinine increased—Doxorubicin—uterine cancer	0.000208	0.000853	CcSEcCtD
Pentamidine—Asthma—Epirubicin—uterine cancer	0.000207	0.00085	CcSEcCtD
Pentamidine—Influenza—Epirubicin—uterine cancer	0.000207	0.00085	CcSEcCtD
Pentamidine—Thrombocytopenia—Etoposide—uterine cancer	0.000206	0.000844	CcSEcCtD
Pentamidine—Tachycardia—Etoposide—uterine cancer	0.000205	0.000842	CcSEcCtD
Pentamidine—Eosinophilia—Epirubicin—uterine cancer	0.000205	0.000842	CcSEcCtD
Pentamidine—Liver function test abnormal—Doxorubicin—uterine cancer	0.000205	0.00084	CcSEcCtD
Pentamidine—Dry skin—Doxorubicin—uterine cancer	0.000203	0.000834	CcSEcCtD
Pentamidine—Pancreatitis—Epirubicin—uterine cancer	0.000203	0.000833	CcSEcCtD
Pentamidine—Anorexia—Etoposide—uterine cancer	0.0002	0.000822	CcSEcCtD
Pentamidine—Bronchitis—Epirubicin—uterine cancer	0.000199	0.000818	CcSEcCtD
Pentamidine—Diarrhoea—Dactinomycin—uterine cancer	0.000199	0.000815	CcSEcCtD
Pentamidine—Pancytopenia—Epirubicin—uterine cancer	0.000197	0.000807	CcSEcCtD
Pentamidine—Hypotension—Etoposide—uterine cancer	0.000196	0.000806	CcSEcCtD
Pentamidine—Gastritis—Doxorubicin—uterine cancer	0.000196	0.000805	CcSEcCtD
Pentamidine—Neutropenia—Epirubicin—uterine cancer	0.000194	0.000795	CcSEcCtD
Pentamidine—Influenza—Doxorubicin—uterine cancer	0.000192	0.000787	CcSEcCtD
Pentamidine—Asthma—Doxorubicin—uterine cancer	0.000192	0.000787	CcSEcCtD
Pentamidine—Eosinophilia—Doxorubicin—uterine cancer	0.00019	0.000779	CcSEcCtD
Pentamidine—Paraesthesia—Etoposide—uterine cancer	0.000189	0.000774	CcSEcCtD
Pentamidine—Pancreatitis—Doxorubicin—uterine cancer	0.000188	0.000771	CcSEcCtD
Pentamidine—Dyspnoea—Etoposide—uterine cancer	0.000187	0.000769	CcSEcCtD
Pentamidine—Hyperglycaemia—Epirubicin—uterine cancer	0.000187	0.000767	CcSEcCtD
Pentamidine—Somnolence—Etoposide—uterine cancer	0.000187	0.000767	CcSEcCtD
Pentamidine—Drowsiness—Epirubicin—uterine cancer	0.000185	0.000758	CcSEcCtD
Pentamidine—Vomiting—Dactinomycin—uterine cancer	0.000185	0.000758	CcSEcCtD
Pentamidine—Bronchitis—Doxorubicin—uterine cancer	0.000184	0.000756	CcSEcCtD
Pentamidine—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000183	0.000751	CcSEcCtD
Pentamidine—Rash—Dactinomycin—uterine cancer	0.000183	0.000751	CcSEcCtD
Pentamidine—Decreased appetite—Etoposide—uterine cancer	0.000183	0.00075	CcSEcCtD
Pentamidine—Pancytopenia—Doxorubicin—uterine cancer	0.000182	0.000747	CcSEcCtD
Pentamidine—Renal failure—Epirubicin—uterine cancer	0.000182	0.000745	CcSEcCtD
Pentamidine—Fatigue—Etoposide—uterine cancer	0.000181	0.000743	CcSEcCtD
Pentamidine—Neuropathy peripheral—Epirubicin—uterine cancer	0.000181	0.000743	CcSEcCtD
Pentamidine—Stomatitis—Epirubicin—uterine cancer	0.00018	0.000739	CcSEcCtD
Pentamidine—Constipation—Etoposide—uterine cancer	0.00018	0.000737	CcSEcCtD
Pentamidine—Pain—Etoposide—uterine cancer	0.00018	0.000737	CcSEcCtD
Pentamidine—Conjunctivitis—Epirubicin—uterine cancer	0.000179	0.000737	CcSEcCtD
Pentamidine—Neutropenia—Doxorubicin—uterine cancer	0.000179	0.000735	CcSEcCtD
Pentamidine—Haematuria—Epirubicin—uterine cancer	0.000176	0.000723	CcSEcCtD
Pentamidine—Sinusitis—Epirubicin—uterine cancer	0.000173	0.000711	CcSEcCtD
Pentamidine—Feeling abnormal—Etoposide—uterine cancer	0.000173	0.000711	CcSEcCtD
Pentamidine—Hyperglycaemia—Doxorubicin—uterine cancer	0.000173	0.00071	CcSEcCtD
Pentamidine—Nausea—Dactinomycin—uterine cancer	0.000172	0.000708	CcSEcCtD
Pentamidine—Gastrointestinal pain—Etoposide—uterine cancer	0.000172	0.000705	CcSEcCtD
Pentamidine—Drowsiness—Doxorubicin—uterine cancer	0.000171	0.000701	CcSEcCtD
Pentamidine—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000169	0.000695	CcSEcCtD
Pentamidine—Bradycardia—Epirubicin—uterine cancer	0.000169	0.000693	CcSEcCtD
Pentamidine—Renal failure—Doxorubicin—uterine cancer	0.000168	0.000689	CcSEcCtD
Pentamidine—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000167	0.000687	CcSEcCtD
Pentamidine—Urticaria—Etoposide—uterine cancer	0.000167	0.000685	CcSEcCtD
Pentamidine—Stomatitis—Doxorubicin—uterine cancer	0.000167	0.000684	CcSEcCtD
Pentamidine—Rhinitis—Epirubicin—uterine cancer	0.000166	0.000682	CcSEcCtD
Pentamidine—Body temperature increased—Etoposide—uterine cancer	0.000166	0.000682	CcSEcCtD
Pentamidine—Abdominal pain—Etoposide—uterine cancer	0.000166	0.000682	CcSEcCtD
Pentamidine—Conjunctivitis—Doxorubicin—uterine cancer	0.000166	0.000682	CcSEcCtD
Pentamidine—Hepatitis—Epirubicin—uterine cancer	0.000166	0.00068	CcSEcCtD
Pentamidine—Hypoaesthesia—Epirubicin—uterine cancer	0.000165	0.000677	CcSEcCtD
Pentamidine—Pharyngitis—Epirubicin—uterine cancer	0.000165	0.000675	CcSEcCtD
Pentamidine—Oedema peripheral—Epirubicin—uterine cancer	0.000163	0.00067	CcSEcCtD
Pentamidine—Haematuria—Doxorubicin—uterine cancer	0.000163	0.000669	CcSEcCtD
Pentamidine—Sinusitis—Doxorubicin—uterine cancer	0.00016	0.000658	CcSEcCtD
Pentamidine—Erythema multiforme—Epirubicin—uterine cancer	0.000157	0.000643	CcSEcCtD
Pentamidine—Bradycardia—Doxorubicin—uterine cancer	0.000156	0.000641	CcSEcCtD
Pentamidine—Hypersensitivity—Etoposide—uterine cancer	0.000155	0.000635	CcSEcCtD
Pentamidine—Flushing—Epirubicin—uterine cancer	0.000154	0.000631	CcSEcCtD
Pentamidine—Rhinitis—Doxorubicin—uterine cancer	0.000154	0.000631	CcSEcCtD
Pentamidine—Hepatitis—Doxorubicin—uterine cancer	0.000153	0.00063	CcSEcCtD
Pentamidine—Hypoaesthesia—Doxorubicin—uterine cancer	0.000153	0.000626	CcSEcCtD
Pentamidine—Pharyngitis—Doxorubicin—uterine cancer	0.000152	0.000625	CcSEcCtD
Pentamidine—Oedema peripheral—Doxorubicin—uterine cancer	0.000151	0.00062	CcSEcCtD
Pentamidine—Asthenia—Etoposide—uterine cancer	0.000151	0.000619	CcSEcCtD
Pentamidine—Chills—Epirubicin—uterine cancer	0.000149	0.000611	CcSEcCtD
Pentamidine—Pruritus—Etoposide—uterine cancer	0.000149	0.00061	CcSEcCtD
Pentamidine—Arrhythmia—Epirubicin—uterine cancer	0.000148	0.000608	CcSEcCtD
Pentamidine—Erythema multiforme—Doxorubicin—uterine cancer	0.000145	0.000595	CcSEcCtD
Pentamidine—Erythema—Epirubicin—uterine cancer	0.000144	0.000592	CcSEcCtD
Pentamidine—Diarrhoea—Etoposide—uterine cancer	0.000144	0.00059	CcSEcCtD
Pentamidine—Flushing—Doxorubicin—uterine cancer	0.000142	0.000584	CcSEcCtD
Pentamidine—Tension—Epirubicin—uterine cancer	0.000142	0.000581	CcSEcCtD
Pentamidine—Dysgeusia—Epirubicin—uterine cancer	0.000141	0.00058	CcSEcCtD
Pentamidine—Nervousness—Epirubicin—uterine cancer	0.00014	0.000575	CcSEcCtD
Pentamidine—Dizziness—Etoposide—uterine cancer	0.000139	0.00057	CcSEcCtD
Pentamidine—Chills—Doxorubicin—uterine cancer	0.000138	0.000565	CcSEcCtD
Pentamidine—Arrhythmia—Doxorubicin—uterine cancer	0.000137	0.000562	CcSEcCtD
Pentamidine—Vision blurred—Epirubicin—uterine cancer	0.000136	0.000558	CcSEcCtD
Pentamidine—Vomiting—Etoposide—uterine cancer	0.000134	0.000548	CcSEcCtD
Pentamidine—Erythema—Doxorubicin—uterine cancer	0.000134	0.000548	CcSEcCtD
Pentamidine—Anaemia—Epirubicin—uterine cancer	0.000133	0.000547	CcSEcCtD
Pentamidine—Rash—Etoposide—uterine cancer	0.000132	0.000544	CcSEcCtD
Pentamidine—Dermatitis—Etoposide—uterine cancer	0.000132	0.000543	CcSEcCtD
Pentamidine—Headache—Etoposide—uterine cancer	0.000132	0.00054	CcSEcCtD
Pentamidine—Tension—Doxorubicin—uterine cancer	0.000131	0.000538	CcSEcCtD
Pentamidine—Dysgeusia—Doxorubicin—uterine cancer	0.000131	0.000537	CcSEcCtD
Pentamidine—Nervousness—Doxorubicin—uterine cancer	0.00013	0.000532	CcSEcCtD
Pentamidine—Vertigo—Epirubicin—uterine cancer	0.00013	0.000532	CcSEcCtD
Pentamidine—Syncope—Epirubicin—uterine cancer	0.000129	0.000531	CcSEcCtD
Pentamidine—Leukopenia—Epirubicin—uterine cancer	0.000129	0.00053	CcSEcCtD
Pentamidine—Palpitations—Epirubicin—uterine cancer	0.000128	0.000523	CcSEcCtD
Pentamidine—Loss of consciousness—Epirubicin—uterine cancer	0.000127	0.000521	CcSEcCtD
Pentamidine—Cough—Epirubicin—uterine cancer	0.000126	0.000517	CcSEcCtD
Pentamidine—Vision blurred—Doxorubicin—uterine cancer	0.000126	0.000516	CcSEcCtD
Pentamidine—Convulsion—Epirubicin—uterine cancer	0.000125	0.000513	CcSEcCtD
Pentamidine—Nausea—Etoposide—uterine cancer	0.000125	0.000512	CcSEcCtD
Pentamidine—Hypertension—Epirubicin—uterine cancer	0.000125	0.000511	CcSEcCtD
Pentamidine—Anaemia—Doxorubicin—uterine cancer	0.000123	0.000507	CcSEcCtD
Pentamidine—Myalgia—Epirubicin—uterine cancer	0.000123	0.000504	CcSEcCtD
Pentamidine—Chest pain—Epirubicin—uterine cancer	0.000123	0.000504	CcSEcCtD
Pentamidine—Arthralgia—Epirubicin—uterine cancer	0.000123	0.000504	CcSEcCtD
Pentamidine—Anxiety—Epirubicin—uterine cancer	0.000122	0.000503	CcSEcCtD
Pentamidine—Discomfort—Epirubicin—uterine cancer	0.000121	0.000498	CcSEcCtD
Pentamidine—Dry mouth—Epirubicin—uterine cancer	0.00012	0.000493	CcSEcCtD
Pentamidine—Vertigo—Doxorubicin—uterine cancer	0.00012	0.000492	CcSEcCtD
Pentamidine—Syncope—Doxorubicin—uterine cancer	0.00012	0.000491	CcSEcCtD
Pentamidine—Leukopenia—Doxorubicin—uterine cancer	0.00012	0.000491	CcSEcCtD
Pentamidine—Confusional state—Epirubicin—uterine cancer	0.000119	0.000487	CcSEcCtD
Pentamidine—Palpitations—Doxorubicin—uterine cancer	0.000118	0.000484	CcSEcCtD
Pentamidine—Anaphylactic shock—Epirubicin—uterine cancer	0.000118	0.000483	CcSEcCtD
Pentamidine—Loss of consciousness—Doxorubicin—uterine cancer	0.000117	0.000482	CcSEcCtD
Pentamidine—Infection—Epirubicin—uterine cancer	0.000117	0.00048	CcSEcCtD
Pentamidine—Cough—Doxorubicin—uterine cancer	0.000117	0.000478	CcSEcCtD
Pentamidine—Shock—Epirubicin—uterine cancer	0.000116	0.000476	CcSEcCtD
Pentamidine—Convulsion—Doxorubicin—uterine cancer	0.000116	0.000475	CcSEcCtD
Pentamidine—Thrombocytopenia—Epirubicin—uterine cancer	0.000115	0.000473	CcSEcCtD
Pentamidine—Hypertension—Doxorubicin—uterine cancer	0.000115	0.000473	CcSEcCtD
Pentamidine—Tachycardia—Epirubicin—uterine cancer	0.000115	0.000472	CcSEcCtD
Pentamidine—Chest pain—Doxorubicin—uterine cancer	0.000114	0.000467	CcSEcCtD
Pentamidine—Arthralgia—Doxorubicin—uterine cancer	0.000114	0.000467	CcSEcCtD
Pentamidine—Myalgia—Doxorubicin—uterine cancer	0.000114	0.000467	CcSEcCtD
Pentamidine—Anxiety—Doxorubicin—uterine cancer	0.000113	0.000465	CcSEcCtD
Pentamidine—Discomfort—Doxorubicin—uterine cancer	0.000112	0.000461	CcSEcCtD
Pentamidine—Anorexia—Epirubicin—uterine cancer	0.000112	0.000461	CcSEcCtD
Pentamidine—Dry mouth—Doxorubicin—uterine cancer	0.000111	0.000456	CcSEcCtD
Pentamidine—Hypotension—Epirubicin—uterine cancer	0.00011	0.000452	CcSEcCtD
Pentamidine—Confusional state—Doxorubicin—uterine cancer	0.00011	0.000451	CcSEcCtD
Pentamidine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000109	0.000447	CcSEcCtD
Pentamidine—Infection—Doxorubicin—uterine cancer	0.000108	0.000444	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000107	0.00044	CcSEcCtD
Pentamidine—Shock—Doxorubicin—uterine cancer	0.000107	0.00044	CcSEcCtD
Pentamidine—Thrombocytopenia—Doxorubicin—uterine cancer	0.000107	0.000438	CcSEcCtD
Pentamidine—Insomnia—Epirubicin—uterine cancer	0.000107	0.000437	CcSEcCtD
Pentamidine—Tachycardia—Doxorubicin—uterine cancer	0.000106	0.000437	CcSEcCtD
Pentamidine—Paraesthesia—Epirubicin—uterine cancer	0.000106	0.000434	CcSEcCtD
Pentamidine—Dyspnoea—Epirubicin—uterine cancer	0.000105	0.000431	CcSEcCtD
Pentamidine—Somnolence—Epirubicin—uterine cancer	0.000105	0.00043	CcSEcCtD
Pentamidine—Anorexia—Doxorubicin—uterine cancer	0.000104	0.000426	CcSEcCtD
Pentamidine—Dyspepsia—Epirubicin—uterine cancer	0.000104	0.000426	CcSEcCtD
Pentamidine—Decreased appetite—Epirubicin—uterine cancer	0.000102	0.00042	CcSEcCtD
Pentamidine—Hypotension—Doxorubicin—uterine cancer	0.000102	0.000418	CcSEcCtD
Pentamidine—Fatigue—Epirubicin—uterine cancer	0.000102	0.000417	CcSEcCtD
Pentamidine—Pain—Epirubicin—uterine cancer	0.000101	0.000413	CcSEcCtD
Pentamidine—Constipation—Epirubicin—uterine cancer	0.000101	0.000413	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	9.93e-05	0.000408	CcSEcCtD
Pentamidine—Insomnia—Doxorubicin—uterine cancer	9.86e-05	0.000405	CcSEcCtD
Pentamidine—Paraesthesia—Doxorubicin—uterine cancer	9.78e-05	0.000402	CcSEcCtD
Pentamidine—Dyspnoea—Doxorubicin—uterine cancer	9.71e-05	0.000399	CcSEcCtD
Pentamidine—Feeling abnormal—Epirubicin—uterine cancer	9.7e-05	0.000398	CcSEcCtD
Pentamidine—Somnolence—Doxorubicin—uterine cancer	9.69e-05	0.000398	CcSEcCtD
Pentamidine—Gastrointestinal pain—Epirubicin—uterine cancer	9.63e-05	0.000395	CcSEcCtD
Pentamidine—Dyspepsia—Doxorubicin—uterine cancer	9.59e-05	0.000394	CcSEcCtD
Pentamidine—Decreased appetite—Doxorubicin—uterine cancer	9.47e-05	0.000389	CcSEcCtD
Pentamidine—Fatigue—Doxorubicin—uterine cancer	9.39e-05	0.000386	CcSEcCtD
Pentamidine—Urticaria—Epirubicin—uterine cancer	9.36e-05	0.000384	CcSEcCtD
Pentamidine—Pain—Doxorubicin—uterine cancer	9.32e-05	0.000382	CcSEcCtD
Pentamidine—Constipation—Doxorubicin—uterine cancer	9.32e-05	0.000382	CcSEcCtD
Pentamidine—Body temperature increased—Epirubicin—uterine cancer	9.31e-05	0.000382	CcSEcCtD
Pentamidine—Abdominal pain—Epirubicin—uterine cancer	9.31e-05	0.000382	CcSEcCtD
Pentamidine—Feeling abnormal—Doxorubicin—uterine cancer	8.98e-05	0.000369	CcSEcCtD
Pentamidine—Gastrointestinal pain—Doxorubicin—uterine cancer	8.91e-05	0.000366	CcSEcCtD
Pentamidine—Hypersensitivity—Epirubicin—uterine cancer	8.68e-05	0.000356	CcSEcCtD
Pentamidine—Urticaria—Doxorubicin—uterine cancer	8.66e-05	0.000355	CcSEcCtD
Pentamidine—Body temperature increased—Doxorubicin—uterine cancer	8.61e-05	0.000354	CcSEcCtD
Pentamidine—Abdominal pain—Doxorubicin—uterine cancer	8.61e-05	0.000354	CcSEcCtD
Pentamidine—Asthenia—Epirubicin—uterine cancer	8.45e-05	0.000347	CcSEcCtD
Pentamidine—Pruritus—Epirubicin—uterine cancer	8.33e-05	0.000342	CcSEcCtD
Pentamidine—Diarrhoea—Epirubicin—uterine cancer	8.06e-05	0.000331	CcSEcCtD
Pentamidine—Hypersensitivity—Doxorubicin—uterine cancer	8.03e-05	0.00033	CcSEcCtD
Pentamidine—Asthenia—Doxorubicin—uterine cancer	7.82e-05	0.000321	CcSEcCtD
Pentamidine—Dizziness—Epirubicin—uterine cancer	7.79e-05	0.00032	CcSEcCtD
Pentamidine—Pruritus—Doxorubicin—uterine cancer	7.71e-05	0.000316	CcSEcCtD
Pentamidine—Vomiting—Epirubicin—uterine cancer	7.49e-05	0.000307	CcSEcCtD
Pentamidine—Diarrhoea—Doxorubicin—uterine cancer	7.46e-05	0.000306	CcSEcCtD
Pentamidine—Rash—Epirubicin—uterine cancer	7.43e-05	0.000305	CcSEcCtD
Pentamidine—Dermatitis—Epirubicin—uterine cancer	7.42e-05	0.000305	CcSEcCtD
Pentamidine—Headache—Epirubicin—uterine cancer	7.38e-05	0.000303	CcSEcCtD
Pentamidine—Dizziness—Doxorubicin—uterine cancer	7.21e-05	0.000296	CcSEcCtD
Pentamidine—Nausea—Epirubicin—uterine cancer	7e-05	0.000287	CcSEcCtD
Pentamidine—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	6.99e-05	0.00161	CbGpPWpGaD
Pentamidine—CYP2C8—Biological oxidations—CYP19A1—uterine cancer	6.97e-05	0.0016	CbGpPWpGaD
Pentamidine—Vomiting—Doxorubicin—uterine cancer	6.93e-05	0.000284	CcSEcCtD
Pentamidine—Rash—Doxorubicin—uterine cancer	6.87e-05	0.000282	CcSEcCtD
Pentamidine—CYP2C8—Metapathway biotransformation—CYP19A1—uterine cancer	6.87e-05	0.00158	CbGpPWpGaD
Pentamidine—Dermatitis—Doxorubicin—uterine cancer	6.86e-05	0.000282	CcSEcCtD
Pentamidine—Headache—Doxorubicin—uterine cancer	6.83e-05	0.00028	CcSEcCtD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	6.63e-05	0.00152	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	6.63e-05	0.00152	CbGpPWpGaD
Pentamidine—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	6.59e-05	0.00151	CbGpPWpGaD
Pentamidine—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	6.49e-05	0.00149	CbGpPWpGaD
Pentamidine—Nausea—Doxorubicin—uterine cancer	6.47e-05	0.000266	CcSEcCtD
Pentamidine—S100B—Innate Immune System—ERBB2—uterine cancer	6.42e-05	0.00147	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—AKR1C3—uterine cancer	6.33e-05	0.00145	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	6.32e-05	0.00145	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	6.32e-05	0.00145	CbGpPWpGaD
Pentamidine—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	6.22e-05	0.00143	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PGR—uterine cancer	6.17e-05	0.00142	CbGpPWpGaD
Pentamidine—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	6.15e-05	0.00141	CbGpPWpGaD
Pentamidine—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	6.13e-05	0.00141	CbGpPWpGaD
Pentamidine—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	6.13e-05	0.00141	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	6.08e-05	0.0014	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—STAR—uterine cancer	6.08e-05	0.0014	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	5.95e-05	0.00137	CbGpPWpGaD
Pentamidine—S100B—Immune System—FGFR2—uterine cancer	5.95e-05	0.00137	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—CDKN1B—uterine cancer	5.94e-05	0.00137	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—YWHAE—uterine cancer	5.88e-05	0.00135	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	5.85e-05	0.00134	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—POLD1—uterine cancer	5.84e-05	0.00134	CbGpPWpGaD
Pentamidine—CYP2D6—Biological oxidations—CYP19A1—uterine cancer	5.72e-05	0.00131	CbGpPWpGaD
Pentamidine—CYP2D6—Metapathway biotransformation—CYP19A1—uterine cancer	5.64e-05	0.0013	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—FBXW7—uterine cancer	5.64e-05	0.0013	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—CTNNB1—uterine cancer	5.61e-05	0.00129	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	5.55e-05	0.00127	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	5.55e-05	0.00127	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—PTEN—uterine cancer	5.47e-05	0.00126	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—AKR1C1—uterine cancer	5.46e-05	0.00125	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	5.42e-05	0.00125	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	5.42e-05	0.00125	CbGpPWpGaD
Pentamidine—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	5.4e-05	0.00124	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	5.25e-05	0.00121	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—EP300—uterine cancer	5.22e-05	0.0012	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	5.19e-05	0.00119	CbGpPWpGaD
Pentamidine—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	5.08e-05	0.00117	CbGpPWpGaD
Pentamidine—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	5.01e-05	0.00115	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—STK11—uterine cancer	4.93e-05	0.00113	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—NRAS—uterine cancer	4.88e-05	0.00112	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—RRM2—uterine cancer	4.87e-05	0.00112	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.86e-05	0.00112	CbGpPWpGaD
Pentamidine—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	4.84e-05	0.00111	CbGpPWpGaD
Pentamidine—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	4.78e-05	0.0011	CbGpPWpGaD
Pentamidine—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	4.73e-05	0.00109	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—DCN—uterine cancer	4.72e-05	0.00109	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—SOCS3—uterine cancer	4.62e-05	0.00106	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	4.47e-05	0.00103	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	4.46e-05	0.00102	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—CYP11A1—uterine cancer	4.45e-05	0.00102	CbGpPWpGaD
Pentamidine—S100B—Immune System—CDH1—uterine cancer	4.43e-05	0.00102	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CDKN2B—uterine cancer	4.42e-05	0.00102	CbGpPWpGaD
Pentamidine—CYP1A1—PPARA activates gene expression—EP300—uterine cancer	4.33e-05	0.000995	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—NDUFB11—uterine cancer	4.32e-05	0.000993	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—SRD5A2—uterine cancer	4.32e-05	0.000993	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—IGF1R—uterine cancer	4.29e-05	0.000986	CbGpPWpGaD
Pentamidine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—uterine cancer	4.24e-05	0.000974	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	4.23e-05	0.000971	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	4.23e-05	0.000971	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—AKR1C3—uterine cancer	4.2e-05	0.000966	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—KRAS—uterine cancer	4.2e-05	0.000965	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—SRD5A2—uterine cancer	4.08e-05	0.000938	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—NDUFB11—uterine cancer	4.08e-05	0.000938	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—SMAD3—uterine cancer	4.03e-05	0.000927	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.98e-05	0.000915	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.97e-05	0.000911	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—PIK3CA—uterine cancer	3.86e-05	0.000887	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—FGFR2—uterine cancer	3.85e-05	0.000884	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	3.8e-05	0.000873	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.75e-05	0.000861	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—SRD5A2—uterine cancer	3.74e-05	0.00086	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—NDUFB11—uterine cancer	3.74e-05	0.00086	CbGpPWpGaD
Pentamidine—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	3.74e-05	0.000859	CbGpPWpGaD
Pentamidine—S100B—Immune System—ERBB2—uterine cancer	3.74e-05	0.000859	CbGpPWpGaD
Pentamidine—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	3.69e-05	0.000847	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.64e-05	0.000836	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—HRAS—uterine cancer	3.57e-05	0.000821	CbGpPWpGaD
Pentamidine—S100B—Immune System—CDKN1B—uterine cancer	3.46e-05	0.000795	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.43e-05	0.000789	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—NDUFB11—uterine cancer	3.34e-05	0.000768	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—SRD5A2—uterine cancer	3.34e-05	0.000768	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—ESR1—uterine cancer	3.29e-05	0.000756	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—STK11—uterine cancer	3.27e-05	0.000752	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—CYP19A1—uterine cancer	3.27e-05	0.000752	CbGpPWpGaD
Pentamidine—S100B—Immune System—CTNNB1—uterine cancer	3.27e-05	0.000751	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.25e-05	0.000746	CbGpPWpGaD
Pentamidine—S100B—Immune System—PTEN—uterine cancer	3.19e-05	0.000732	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—AKT1—uterine cancer	3.15e-05	0.000725	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—AKR1B1—uterine cancer	3.12e-05	0.000718	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—STAR—uterine cancer	3.12e-05	0.000718	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.1e-05	0.000713	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.07e-05	0.000706	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—NDUFB11—uterine cancer	3.07e-05	0.000706	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—SRD5A2—uterine cancer	3.07e-05	0.000706	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.06e-05	0.000704	CbGpPWpGaD
Pentamidine—S100B—Immune System—EP300—uterine cancer	3.04e-05	0.000698	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—AKR1B1—uterine cancer	2.95e-05	0.000678	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—STAR—uterine cancer	2.95e-05	0.000678	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.93e-05	0.000674	CbGpPWpGaD
Pentamidine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—uterine cancer	2.92e-05	0.000671	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.92e-05	0.00067	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CCL2—uterine cancer	2.9e-05	0.000666	CbGpPWpGaD
Pentamidine—S100B—Immune System—NRAS—uterine cancer	2.84e-05	0.000653	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—AKR1B1—uterine cancer	2.71e-05	0.000622	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—STAR—uterine cancer	2.71e-05	0.000622	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.67e-05	0.000615	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—SRD5A2—uterine cancer	2.6e-05	0.000598	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NDUFB11—uterine cancer	2.6e-05	0.000598	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.53e-05	0.000581	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—MTHFR—uterine cancer	2.46e-05	0.000565	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—POLD1—uterine cancer	2.45e-05	0.000563	CbGpPWpGaD
Pentamidine—S100B—Immune System—KRAS—uterine cancer	2.45e-05	0.000562	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—ERBB2—uterine cancer	2.42e-05	0.000555	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—AKR1B1—uterine cancer	2.42e-05	0.000555	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—STAR—uterine cancer	2.42e-05	0.000555	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.39e-05	0.000549	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.39e-05	0.000549	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—POLD1—uterine cancer	2.32e-05	0.000532	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—AKR1C1—uterine cancer	2.29e-05	0.000527	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CXCL8—uterine cancer	2.29e-05	0.000527	CbGpPWpGaD
Pentamidine—S100B—Immune System—PIK3CA—uterine cancer	2.25e-05	0.000517	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CDKN1B—uterine cancer	2.24e-05	0.000514	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—STAR—uterine cancer	2.22e-05	0.000511	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—AKR1B1—uterine cancer	2.22e-05	0.000511	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.17e-05	0.000498	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—AKR1C1—uterine cancer	2.17e-05	0.000498	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—POLD1—uterine cancer	2.12e-05	0.000488	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CTNNB1—uterine cancer	2.11e-05	0.000486	CbGpPWpGaD
Pentamidine—S100B—Immune System—HRAS—uterine cancer	2.08e-05	0.000478	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PTEN—uterine cancer	2.06e-05	0.000473	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—RRM2—uterine cancer	2.04e-05	0.00047	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—SRD5A2—uterine cancer	2.01e-05	0.000462	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NDUFB11—uterine cancer	2.01e-05	0.000462	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.99e-05	0.000456	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—DCN—uterine cancer	1.98e-05	0.000456	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—EP300—uterine cancer	1.96e-05	0.000452	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—RRM2—uterine cancer	1.93e-05	0.000444	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—POLD1—uterine cancer	1.9e-05	0.000436	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.88e-05	0.000433	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—STAR—uterine cancer	1.88e-05	0.000433	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—DCN—uterine cancer	1.87e-05	0.000431	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CYP11A1—uterine cancer	1.87e-05	0.00043	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—VEGFA—uterine cancer	1.86e-05	0.000428	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.86e-05	0.000428	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—NRAS—uterine cancer	1.84e-05	0.000422	CbGpPWpGaD
Pentamidine—S100B—Immune System—AKT1—uterine cancer	1.84e-05	0.000422	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.77e-05	0.000407	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—RRM2—uterine cancer	1.77e-05	0.000407	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CYP11A1—uterine cancer	1.77e-05	0.000406	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—AKR1C3—uterine cancer	1.77e-05	0.000406	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—POLD1—uterine cancer	1.74e-05	0.000401	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—DCN—uterine cancer	1.72e-05	0.000395	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—AKR1C3—uterine cancer	1.67e-05	0.000383	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—AKR1C1—uterine cancer	1.63e-05	0.000375	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.62e-05	0.000372	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—KRAS—uterine cancer	1.58e-05	0.000364	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—RRM2—uterine cancer	1.58e-05	0.000363	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—DCN—uterine cancer	1.53e-05	0.000353	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—AKR1C3—uterine cancer	1.53e-05	0.000351	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—POLD1—uterine cancer	1.48e-05	0.000339	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PIK3CA—uterine cancer	1.45e-05	0.000334	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—RRM2—uterine cancer	1.45e-05	0.000334	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—STAR—uterine cancer	1.45e-05	0.000334	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.45e-05	0.000334	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP11A1—uterine cancer	1.45e-05	0.000332	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—DCN—uterine cancer	1.41e-05	0.000324	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—TP53—uterine cancer	1.41e-05	0.000323	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—AKR1C1—uterine cancer	1.38e-05	0.000317	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CYP19A1—uterine cancer	1.38e-05	0.000316	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—STK11—uterine cancer	1.38e-05	0.000316	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PTEN—uterine cancer	1.37e-05	0.000315	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—AKR1C3—uterine cancer	1.36e-05	0.000314	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—HRAS—uterine cancer	1.34e-05	0.000309	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP11A1—uterine cancer	1.33e-05	0.000305	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—EP300—uterine cancer	1.31e-05	0.0003	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—STK11—uterine cancer	1.3e-05	0.000299	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—CYP19A1—uterine cancer	1.3e-05	0.000299	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—AKR1C3—uterine cancer	1.26e-05	0.000288	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—RRM2—uterine cancer	1.23e-05	0.000283	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.22e-05	0.00028	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—DCN—uterine cancer	1.2e-05	0.000275	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYP19A1—uterine cancer	1.19e-05	0.000274	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—STK11—uterine cancer	1.19e-05	0.000274	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—AKT1—uterine cancer	1.19e-05	0.000273	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.16e-05	0.000267	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—POLD1—uterine cancer	1.14e-05	0.000262	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP11A1—uterine cancer	1.13e-05	0.000259	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.12e-05	0.000257	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.07e-05	0.000245	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.07e-05	0.000245	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—AKR1C3—uterine cancer	1.06e-05	0.000244	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—STK11—uterine cancer	1.06e-05	0.000244	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP19A1—uterine cancer	1.06e-05	0.000244	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—MTHFR—uterine cancer	1.03e-05	0.000238	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.98e-06	0.000229	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—STK11—uterine cancer	9.78e-06	0.000225	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP19A1—uterine cancer	9.78e-06	0.000225	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—MTHFR—uterine cancer	9.76e-06	0.000224	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PIK3CA—uterine cancer	9.66e-06	0.000222	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.52e-06	0.000219	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—RRM2—uterine cancer	9.5e-06	0.000218	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—DCN—uterine cancer	9.23e-06	0.000212	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—MTHFR—uterine cancer	8.95e-06	0.000206	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP11A1—uterine cancer	8.69e-06	0.0002	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.6e-06	0.000198	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—STK11—uterine cancer	8.29e-06	0.00019	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP19A1—uterine cancer	8.29e-06	0.00019	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—AKR1C3—uterine cancer	8.21e-06	0.000189	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—MTHFR—uterine cancer	7.99e-06	0.000184	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.89e-06	0.000181	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—AKT1—uterine cancer	7.89e-06	0.000181	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.78e-06	0.000179	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	7.42e-06	0.00017	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—MTHFR—uterine cancer	7.35e-06	0.000169	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	7.04e-06	0.000162	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP19A1—uterine cancer	6.39e-06	0.000147	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—STK11—uterine cancer	6.39e-06	0.000147	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—MTHFR—uterine cancer	6.23e-06	0.000143	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PTEN—uterine cancer	5.75e-06	0.000132	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.49e-06	0.000126	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—EP300—uterine cancer	5.48e-06	0.000126	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PTEN—uterine cancer	5.43e-06	0.000125	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—EP300—uterine cancer	5.18e-06	0.000119	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PTEN—uterine cancer	4.98e-06	0.000114	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—MTHFR—uterine cancer	4.81e-06	0.00011	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—EP300—uterine cancer	4.75e-06	0.000109	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PTEN—uterine cancer	4.45e-06	0.000102	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—EP300—uterine cancer	4.24e-06	9.74e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PTEN—uterine cancer	4.09e-06	9.4e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CA—uterine cancer	4.06e-06	9.32e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—EP300—uterine cancer	3.9e-06	8.96e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CA—uterine cancer	3.83e-06	8.81e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CA—uterine cancer	3.51e-06	8.07e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PTEN—uterine cancer	3.46e-06	7.96e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—AKT1—uterine cancer	3.31e-06	7.61e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—EP300—uterine cancer	3.3e-06	7.59e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CA—uterine cancer	3.14e-06	7.21e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—AKT1—uterine cancer	3.13e-06	7.19e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CA—uterine cancer	2.88e-06	6.63e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—AKT1—uterine cancer	2.87e-06	6.6e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PTEN—uterine cancer	2.67e-06	6.14e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—AKT1—uterine cancer	2.56e-06	5.89e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—EP300—uterine cancer	2.55e-06	5.86e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CA—uterine cancer	2.44e-06	5.62e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—AKT1—uterine cancer	2.36e-06	5.41e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—AKT1—uterine cancer	2e-06	4.59e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.89e-06	4.33e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—AKT1—uterine cancer	1.54e-06	3.54e-05	CbGpPWpGaD
